N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide
C26H35N5O2 — CID 155560721
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide
N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide (PubChem CID 155560721) has the molecular formula C26H35N5O2 and a molecular weight of 449.60 g/mol. Its IUPAC name is N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide |
|---|---|
| PubChem CID | 155560721 |
| Molecular Formula | C26H35N5O2 |
| Molecular Weight | 449.60 g/mol |
| Exact Mass | 449.28 |
| IUPAC Name | N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-piperidin-4-yl-1-propan-2-ylindazole-4-carboxamide |
| SMILES | CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(C2CCNCC2)cc2c1cnn2C(C)C |
| InChI | InChI=1S/C26H35N5O2/c1-5-6-19-11-17(4)30-26(33)22(19)14-28-25(32)21-12-20(18-7-9-27-10-8-18)13-24-23(21)15-29-31(24)16(2)3/h11-13,15-16,18,27H,5-10,14H2,1-4H3,(H,28,32)(H,30,33) |
| InChIKey | QKZXBIXAKYLFRD-UHFFFAOYSA-N |
| XLogP | 3.96 |
| TPSA | 91.81 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.60 |
| LogP ≤ 5 | 3.96 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155560721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.